Chemed

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemed exceeds earnings expectations, focuses on strategic growth initiatives

Chemed's strong financial performance in 2022 was supported by targeted hiring and retention efforts.
Both VITAS and Roto-Rooter are focusing on improving staffing and revenue growth.
Chemed's strategic initiatives position the company well for future growth and operational efficiency.
The company's emphasis on culture and strategic approaches enhances valuation in the M&A market.

Chemed reports strong Q1 performance, optimistic about growth trajectory

Chemed's Q1 2023 earnings call highlighted a positive performance trajectory post-pandemic, with a focus on VITAS' growth and operational strategies. The company addressed challenges related to Medicare reimbursement rates and emphasized opportunities for further expansion and staff satisfaction.

Chemed's VITAS shines, Roto-Rooter adapts to consumer challenges

Chemed's Q2 2023 earnings call highlighted VITAS' strong performance and operational improvements post-pandemic.
Roto-Rooter faced challenges in consumer spending but focused on enhancing online presence and conversion rates.
Both segments showcased resilience amidst economic headwinds, with strategic initiatives in place to drive growth and operational efficiency.
Chemed's strategic cost management and revenue generation strategies position the company for sustainable growth and margin protection.

Chemed reports strong Q3 performance, eyes growth amid economic challenges

Chemed's diversified business segments showed resilience and growth potential, with VITAS Healthcare and Roto-Rooter both demonstrating strengths and addressing challenges. The company remains cautiously optimistic about 2024, focusing on operational efficiency and market dynamics for sustained performance.

Chemed's VITAS shines in Q4 with strong growth, Roto-Rooter faces challenges

Chemed's VITAS segment excelled with strong revenue growth and operational improvements, while Roto-Rooter faced challenges in call volume.
Management's confidence in sustained growth and margin improvement presents opportunities for both VITAS and Roto-Rooter in 2024.
Strategies to address challenges and capitalize on opportunities will be crucial for Chemed's divisions to meet their forecasted targets.
Overall, Chemed's performance in Q4 2023 sets a positive tone for the company's outlook and strategic initiatives moving forward.

Chemed excels in hospice segment, Roto-Rooter faces commercial challenges

Chemed's VITAS segment outperformed, while Roto-Rooter faced challenges, prompting strategic actions to enhance commercial performance and drive growth.

Chemed's VITAS shines in Q2 2024, Roto-Rooter faces revenue challenges

Chemed's VITAS segment is driving revenue growth and margin expansion, while Roto-Rooter faces challenges in revenue decline. The company aims to capitalize on growth opportunities in the hospice services sector.

Chemed's VITAS shines amid Roto-Rooter's challenges in Q3 2024

Chemed's earnings call showcased VITAS' resilience and growth prospects, while addressing Roto-Rooter's challenges and strategic adjustments. The company remains optimistic about adjusted net income outlook for the year.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Chemed Corporation (CHE) CEO Kevin McNamara on Q4 2021 Results - Earnings Call Transcript

Chemed (CHE) reports better-than-expected earnings for the fourth quarter, with a robust performance by the Roto-Rooter arm driving the top line.

Chemed (CHE) Q4 Earnings Surpass Estimates, Revenues Miss

Chemed (CHE) delivered earnings and revenue surprises of 3.75% and 0.61%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Chemed (CHE) Q4 Earnings Surpass Estimates

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2021, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 1.4% to $541 million GAAP D

Chemed Reports Fourth-Quarter 2021 Results

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company's capital stock, payable on March 18, 2022, to shareholders of record as of February 28, 2022. This is equal to the dividend paid in December 2021. This represents the 203rd consecutive quarterly dividend paid by Chemed in its 50 years as a public company. Listed on the New York Stock Exchange and headquartered in Cinc

Chemed Corporation Declares Quarterly Dividend of 36 Cents

Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Chemed (CHE) Q4 Earnings Expected to Decline

Addus HomeCare

ADUS vs. CHE: Which Stock Is the Better Value Option?

ADUS or CHE: Which Is the Better Value Stock Right Now?

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2021, on Thursday, February 24, 2022, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, February 25, 2022, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-

Chemed To Report Fourth-Quarter 2021 Earnings February 24, Related Conference Call To Be Held On February 25

Investors are optimistic about Chemed (CHE) on strong third-quarter performance and raised Roto-Rooter and earnings guidance for 2021.

Here's Why You Should Add Chemed (CHE) to Your Portfolio Now

Abbott Labs

Baxter

West Pharmaceutical Services

Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.

4 MedTech Dividend Stocks in Focus on Amid Omicron Variant Panic

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2021 Virtual Home Care Conference on Tuesday, December 7, 2021, at 11:00 AM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New Y

Chemed Corporation to Present at the BofA Securities 2021 Virtual Home Care Conference

Autohome

Dick's Sporting Goods

Ensign Group

Evercore

Gentex

Garmin

Houlihan Lokey

Johnson Outdoors

Kforce

Lithia Motors

Logitech

Medifast

PulteGroup

The American Association of Individual Investors (AAII) publishes monthly tips for members on-line. Their November Journal featured these thirty Buffett-worthy candidates by one of Buffett's closest followers, Robert Hagstrom.

Tracking Warren Buffett's Future Dividend Picks: 21 From AAII's Hagstrom Screen

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Credit Suisse 30th Annual Virtual Healthcare Conference on Wednesday, November 10, 2021, at approximately 1:00 p.m. (ET). The presentation will be webcast live and can be accessed through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days. Listed on the New

Chemed Corporation to Present at the 2021 Credit Suisse Virtual Healthcare Conference

Chemed (CHE) reports better-than-expected earnings and revenues in the third-quarter 2021, with a solid performance by the Roto-Rooter segment driving the top line.

Chemed (CHE) Q3 Earnings Beat Estimates, Full-Year EPS View Up

Chemed Corporation (CHE) CEO Kevin McNamara on Q3 2021 Results - Earnings Call Transcript

Chemed (CHE) delivered earnings and revenue surprises of 13.45% and 1.22%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Chemed (CHE) Q3 Earnings and Revenues Top Estimates

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2021, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 2.0% to $539 million GAAP D

Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2021, on Thursday, October 28, 2021, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, October 29, 2021, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-25

Chemed To Report Third-Quarter 2021 Earnings October 28, Related Conference Call To Be Held On October 29

Credit Acceptance

Stock investing involves agency risk, as outside investors essentially delegate their capital to corporate executives to generate business returns without active participation in the management.

Some Easy-to-Grasp Gimmicks to Gauge Management Compensation

Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Chemed (CHE) Moves to Buy: Rationale Behind the Upgrade

Chemed (CHE) reported earnings 30 days ago. What's next for the stock?

Chemed (CHE) Up 1.9% Since Last Earnings Report: Can It Continue?

Chemed (CHE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Chemed (CHE) Upgraded to Buy: Here's Why

Arbor Realty Trust

Bio-Rad Laboratories

Cathay General Bancorp

Materialise NV

Increased analyst coverage over the past few weeks might lead to solid price appreciation for stocks like CATY, BIO, CHE, MTLS and ABR.

5 Stocks to Buy as Analysts Initiate Coverage

Cogent Communications Holdings

Carlisle Companies

Dover

Fidelity National Financial

Federal Realty Investment Trust

Illinois Tool Works

KLA-Tencor

Quaker Chemical

Microchip Technology

NewMarket

Terreno Realty

Willis Towers

This weekly article series provides a summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases.

Dividend Increases: July 31-August 6, 2021

Chemed Corporation (CHE) CEO Kevin McNamara on Q2 2021 Results - Earnings Call Transcript

News for Chemed Stock (CHE)